MR. BARRY EIBSCHUTZ M.D.
NPI 1164464566
Internal Medicine - Rheumatology in San Luis Obispo, CA

Active since June 11, 2006PECOS EnrolledAccepts Medicare Assignment
1039 MURRARY ST, SUITE 200, SAN LUIS OBISPO, CA 93405(805) 781-0702(888) 255-4693 Get Directions Write a Review

NPPES record last updated: September 23, 2016. Verified against the NPPES registry weekly; last sync: August 02, 2026.

About Mr. Barry Eibschutz M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

MR. BARRY EIBSCHUTZ M.D. (NPI 1164464566) is an individual rheumatology provider in San Luis Obispo, California, licensed in California (G78005) and active in the NPI registry since June 2006. He is enrolled in Medicare PECOS and is a graduate of Other (1987).

NPPES Registry Identity

NPI1164464566
Entity TypeIndividualMale
Primary Taxonomy207RR0500X
Provider Legal NameMR. BARRY EIBSCHUTZCredential: M.D.
Location Address1039 MURRARY ST, SUITE 200San Luis Obispo, CA 93405-2058
Mailing Address1039 Murrary St, Suite 200San Luis Obispo, CA 93405-2058 · (805) 781-0702 · Fax (888) 225-4693
Fax(888) 255-4693
Sole ProprietorYes
Medical School CMSOtherGraduated 1987
Enumeration DateJune 11, 2006
Last NPPES UpdateSeptember 23, 2016
NPI 1164464566 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyInternal Medicine · RheumatologyAllopathic & Osteopathic Physicians
Taxonomy Code207RR0500X
License Licensed in CA · G78005
Definition
An internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases.
1039 MURRARY ST, San Luis Obispo, CA 93405

Other Identifiers 3

Medicare UPING44801CA
Medicare PING78005ACA
Medicaid00G780050CA

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Mr. Barry Eibschutz M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID941233167
PECOS Enrollment IDI20050916000877
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 25

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, tocilizumab, 1 mg J3262
Tocilizumab is a medication administered via injection. It's used to treat certain conditions like rheumatoid arthritis by reducing inflammation in the body. It works by blocking a substance in the body that leads to inflammation.
200,670 services57 patients
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0717
Certolizumab pegol is a medication injected under a doctor's supervision. It's used to treat certain inflammatory conditions like rheumatoid arthritis. The injection helps reduce symptoms like pain and swelling. Note that this drug isn't for self-administration.
61,300 services21 patients
Injection, romosozumab-aqqg, 1 mg J3111
Romosozumab-aqqg is a medication given by injection to treat osteoporosis in patients at high risk for fractures. It works by increasing bone mass and strength, reducing the risk of fractures.
54,600 services50 patients
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0129
Abatacept is a medication administered via injection under a doctor's supervision. It's used to treat conditions like rheumatoid arthritis by moderating the immune system. This code applies when the doctor administers the drug, not for self-administration.
44,450 services75 patients
Injection, golimumab, 1 mg, for intravenous use J1602
Golimumab is a medication given through an IV (a small tube in your vein). It helps to reduce inflammation and pain by blocking a protein in your body that causes inflammation. It's often used to treat conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
39,545 services47 patients
Injection, rituximab, 10 mg J9312
Rituximab is a medication given via injection. It's used to treat certain types of cancer and autoimmune diseases. The 10 mg dosage refers to the amount of the drug in the injection. It works by targeting and destroying specific cells, helping your body's immune system.
24,500 services66 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 93405 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$135.73 typical visit price
range $59.84 – $178.89
Typical copayment $33.93 (range $14.96 – $44.72)
Most-billed visit code 99204
Established Patient
$104.82 typical visit price
range $19.70 – $146.55
Typical copayment $26.20 (range $4.92 – $36.63)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

Reported Quality Measures

Care Plan
Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker…
93%857 patients4/55-star benchmark: 100%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
100%3,686 patients5/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
8%1,084 patients1/55-star benchmark: 100%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
100%707 patients5/55-star benchmark: 100%
Pain Assessment and Follow-Up
Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present
97%3,671 patients4/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
9%1,080 patients1/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
97%857 patients5/55-star benchmark: 95%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
39%1,080 patients2/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Functional Status Assessment
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) for whom a functional status assessment was performed at least once within 12 months
96%531 patients4/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
27%1,080 patients2/55-star benchmark: 79%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Barry Eibschutz's NPI number?

The NPI number for Barry Eibschutz is 1164464566. It was assigned to this individual provider in the NPPES registry on June 11, 2006.

Where is Barry Eibschutz located?

Barry Eibschutz practices at 1039 Murrary St Suite 200, San Luis Obispo, CA 93405. The listed phone number is (805) 781-0702.

What is Barry Eibschutz's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Rheumatology, with taxonomy code 207RR0500X.

Is Barry Eibschutz enrolled in Medicare?

Yes. Barry Eibschutz is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Barry Eibschutz was last updated on September 23, 2016. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 9 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.